Skip to main content
Caplight Logo









Alphabiome

Alphabiome

Private
IsraelHealthcare & Life Scienceshttps://www.alphabiome.ai/

Last Round

Seed

May 6, 2025

Total Funding Raised

$8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Alphabiome is a biotechnology company that develops an AI-powered platform to analyze microbial genetic data for precision medicine and drug efficacy prediction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbiome analysisbiomarker discoveryprecision medicinedrug discoverybioinformaticsAI biotechagtechpredictive analyticsdata as a serviceDaaSmicrobial genomicsdrug response predictionmethane reductiondigital biologyomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alphabiome Comparables

Compare Alphabiome with similar companies based on industry and business-model similarity.

Alphabiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xbiome
76%
Persephone Biosciences
69%
Ardigen
61%

Alphabiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 6, 2025

Alphabiome Investors

Notable investors and investment history

Alphabiome investors
InvestorRounds
AIX VenturesSeed
New Era Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 216% MoM, reaching 982.

  • Aug 25, 2025

    Grew 125% QoQ from 4 to 9 employees.

Alphabiome Filings

Explore SEC and related filing metadata, where available.

Alphabiome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alphabiome's valuation, stock price, and market status.

Is Alphabiome a public or private company?

Alphabiome is a private company.

What is the current stock price of Alphabiome?

Alphabiome is a private company with no public stock price. No recent secondary market data is available.

How much is Alphabiome worth (valuation)?

Valuation information for Alphabiome is not publicly available.

Can I buy Alphabiome stock?

Alphabiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alphabiome's last funding round?

Alphabiome's most recent funding round was Seed on May 6, 2025.

Who are the main investors in Alphabiome?

Key investors in Alphabiome include AIX Ventures, New Era Capital Partners.

Will Alphabiome IPO soon?

No public IPO plans have been announced for Alphabiome.

How can I track Alphabiome secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alphabiome's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range10
Year Founded2022
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?